Honglin Luo Selected Research

Coxsackievirus Infections

9/2017	Phosphorylation and degradation of αB-crystallin during enterovirus infection facilitates viral replication and induces viral pathogenesis.
1/2017	Cleavage of Grb2-Associated Binding Protein 2 by Viral Proteinase 2A during Coxsackievirus Infection.
10/2015	Dysferlin deficiency confers increased susceptibility to coxsackievirus-induced cardiomyopathy.
1/2011	Tripeptidyl peptidase II serves as an alternative to impaired proteasome to maintain viral growth in the host cells.
7/2008	Ubiquitination is required for effective replication of coxsackievirus B3.
4/2004	Soluble recombinant coxsackievirus and adenovirus receptor abrogates coxsackievirus b3-mediated pancreatitis and myocarditis in mice.
8/2003	Proteasome inhibition reduces coxsackievirus B3 replication in murine cardiomyocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Honglin Luo Research Topics

Disease

48	Infections 01/2022 - 04/2002
17	Virus Diseases (Viral Diseases) 01/2021 - 12/2002
15	Myocarditis (Carditis) 01/2021 - 06/2002
12	Neoplasms (Cancer) 01/2021 - 08/2003
7	Inflammation (Inflammations) 12/2020 - 04/2004
7	Coxsackievirus Infections 09/2017 - 08/2003
3	Enterovirus Infections 01/2019 - 07/2015
2	Lung Neoplasms (Lung Cancer) 03/2021 - 03/2020
2	Breast Neoplasms (Breast Cancer) 12/2020 - 04/2014
2	Neoplasm Metastasis (Metastasis) 12/2020 - 12/2017
2	Cardiomyopathies (Cardiomyopathy) 09/2017 - 10/2015
2	Heart Diseases (Heart Disease) 09/2017 - 01/2003
2	Fibrosis (Cirrhosis) 03/2008 - 07/2007
2	Retinoblastoma (Glioblastoma, Retinal) 12/2007 - 03/2002
1	COVID-19 01/2022
1	Bites and Stings (Sting) 01/2022
1	Poliomyelitis (Polio) 01/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Foot and Mouth Disease Hand (Hand, Foot, Mouth Disease) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 12/2020
1	Thrombosis (Thrombus) 06/2020
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2020
1	Adenocarcinoma of Lung 09/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Gliosis 12/2018
1	Frontotemporal Dementia (Semantic Dementia) 01/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2017
1	Hypoxia (Hypoxemia) 12/2017

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 12/2021 - 04/2002
9	Viral RNAIBA 01/2022 - 01/2003
9	Antiviral Agents (Antivirals)IBA 01/2021 - 06/2004
9	Proteasome Endopeptidase Complex (Proteasome)IBA 07/2013 - 08/2003
8	UbiquitinIBA 12/2018 - 01/2003
7	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 01/2011
5	Messenger RNA (mRNA)IBA 01/2019 - 06/2002
4	Phosphotransferases (Kinase)IBA 12/2021 - 01/2005
4	Viral ProteinsIBA 01/2017 - 11/2010
4	Cyclin D1IBA 12/2007 - 03/2002
4	Mitogen-Activated Protein KinasesIBA 12/2007 - 04/2002
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2012
3	CytokinesIBA 01/2021 - 01/2012
3	CaspasesIBA 11/2015 - 08/2003
3	Matrix Metalloproteinases (MMPs)IBA 03/2008 - 10/2005
2	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2022 - 12/2018
2	RNA (Ribonucleic Acid)IBA 01/2022 - 09/2020
2	MicroRNAs (MicroRNA)IBA 03/2021 - 03/2020
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021 - 01/2020
2	Viral ProteasesIBA 01/2021 - 01/2018
2	Carrier Proteins (Binding Protein)IBA 01/2021 - 01/2017
2	Interferon Type IIBA 01/2021 - 09/2019
2	Durapatite (Hydroxylapatite)IBA 01/2021 - 04/2014
2	Small Interfering RNA (siRNA)IBA 12/2020 - 07/2015
2	Protein Kinases (Protein Kinase)IBA 01/2020 - 11/2005
2	Long Noncoding RNAIBA 01/2019 - 03/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2017 - 07/2005
2	Molecular Chaperones (Chaperone, Molecular)IBA 09/2017 - 07/2010
2	Propofol (Diprivan)FDA LinkGeneric 01/2014 - 11/2009
2	p38 Mitogen-Activated Protein KinasesIBA 03/2009 - 11/2005
2	salicylhydroxamic acid (SHAM)IBA 07/2008 - 01/2003
2	C.I. direct red 80IBA 03/2008 - 03/2006
2	Glycogen Synthase Kinase 3 betaIBA 12/2007 - 04/2005
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 12/2007 - 04/2004
2	beta CateninIBA 12/2007 - 04/2005
2	CollagenIBA 07/2007 - 03/2006
2	Caspase 3 (Caspase-3)IBA 03/2007 - 08/2003
2	Doxycycline (Periostat)FDA LinkGeneric 08/2003 - 06/2002
1	Ribavirin (Virazole)FDA LinkGeneric 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	InterferonsIBA 01/2022
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2022
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 12/2021
1	CalcineurinIBA 12/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 01/2021
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 01/2021
1	polydopamineIBA 01/2021
1	Neoplasm Antigens (Tumor Antigens)IBA 12/2020
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 12/2020
1	Circular RNAIBA 09/2020
1	Untranslated RNA (Noncoding RNA)IBA 09/2020
1	dipeptidyl carboxypeptidase (peptidyl-dipeptidase Dcp)IBA 01/2020
1	Mitogen-Activated Protein Kinase 3IBA 09/2019
1	Capsid Proteins (Capsid Protein)IBA 01/2019
1	InflammasomesIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	NLR ProteinsIBA 01/2019
1	Aligeron (AS 2)IBA 12/2018
1	3C Viral ProteasesIBA 01/2018
1	Oxygen (Dioxygen)IBA 12/2017
1	FluorocarbonsIBA 12/2017

Therapy/Procedure

9	Therapeutics 01/2021 - 07/2005
2	Immunomodulation 01/2022 - 01/2012
1	Immunotherapy 12/2020
1	Prostheses and Implants (Prosthesis) 06/2020
1	Drug Therapy (Chemotherapy) 12/2017
1	Radiotherapy 12/2017
1	Precision Medicine 12/2017
1	Photochemotherapy (Photodynamic Therapy) 12/2017